SCHEMBL27979707

SCHEMBL27979707

[CH2]c1cc2c3ccccc3n(Cc3ccccc3)c2c(C)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPK1 P28482 2/20 0.48
KDM4E B2RXH2 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
DYRK1A Q13627 1/20 0.46
TNF P01375 1/20 0.44
MAPT P10636 3/20 0.44
MCL1 Q07820 1/20 0.44
P2RX4 Q99571 1/20 0.44
ALDH1A1 P00352 5/20 0.43
TSHR P16473 3/20 0.43
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27979721 0.90 MEN1 (0.55) CYP19A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL27891716 0.86 CYP19A1 (0.56) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL27979927 0.85 SIGMAR1 (0.47) CYP19A1SMN1; SMN2MEN1KMT2AMCL1
SCHEMBL27979724 0.83 CYP19A1 (0.49) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL27979861 0.83 CYP19A1 (0.51) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL27908741 0.82 CYP19A1 (0.50) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL27939722 0.82 CYP19A1 (0.50) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL27979691 0.81 ALDH1A1 (0.44) SMN1; SMN2MEN1KMT2AKDM4ETDP1
SCHEMBL2215283 0.81 CYP19A1 (0.49) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL27979694 0.81 MEN1 (0.51) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104177377-A 3-Position diamine beta-carboline alkali compound, and preparation method, medicinal composition and use thereof XINJIANG HUASHIDAN PHARMACEUTICAL RES CO LTD 2014-12-03 CN disclosed